James Healy, Director at Karuna Therapeutics, Inc. (KRTX), bought 124,060 shares at $70.12 ($8.9M) on 2020-09-04, disclosed to the SEC on 2020-09-09.
Open-market purchase of $8.9M KRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.12 | 1,670 | $117K | 1.3% |
| 2 | $70.12 | 1,670 | $117K | 1.3% |
| 3 | $71.30 | 45,317 | $3.2M | 36.3% |
| 4 | $71.30 | 45,317 | $3.2M | 36.3% |
| 5 | $72.73 | 6,461 | $470K | 5.3% |
| 6 | $72.73 | 6,461 |
| $470K |
| 5.3% |
| 7 | $73.59 | 8,330 | $613K | 6.9% |
| 8 | $73.59 | 8,330 | $613K | 6.9% |
| 9 | $73.00 | 504 | $37K | 0.4% |
| Total | $71.73 avg | 124,060 | $8.9M | 100% |
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |